1. Home
  2. SYBX vs TKLF Comparison

SYBX vs TKLF Comparison

Compare SYBX & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYBX
  • TKLF
  • Stock Information
  • Founded
  • SYBX N/A
  • TKLF 2006
  • Country
  • SYBX United States
  • TKLF Japan
  • Employees
  • SYBX N/A
  • TKLF N/A
  • Industry
  • SYBX Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • SYBX Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • SYBX Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • SYBX 16.5M
  • TKLF 15.7M
  • IPO Year
  • SYBX N/A
  • TKLF 2022
  • Fundamental
  • Price
  • SYBX $1.36
  • TKLF $3.90
  • Analyst Decision
  • SYBX Hold
  • TKLF
  • Analyst Count
  • SYBX 1
  • TKLF 0
  • Target Price
  • SYBX N/A
  • TKLF N/A
  • AVG Volume (30 Days)
  • SYBX 19.0K
  • TKLF 19.4K
  • Earning Date
  • SYBX 03-18-2025
  • TKLF 12-18-2024
  • Dividend Yield
  • SYBX N/A
  • TKLF N/A
  • EPS Growth
  • SYBX N/A
  • TKLF N/A
  • EPS
  • SYBX N/A
  • TKLF 1.70
  • Revenue
  • SYBX $2,777,000.00
  • TKLF $219,520,631.00
  • Revenue This Year
  • SYBX N/A
  • TKLF N/A
  • Revenue Next Year
  • SYBX N/A
  • TKLF N/A
  • P/E Ratio
  • SYBX N/A
  • TKLF $2.29
  • Revenue Growth
  • SYBX 292.23
  • TKLF 32.02
  • 52 Week Low
  • SYBX $1.22
  • TKLF $2.00
  • 52 Week High
  • SYBX $2.04
  • TKLF $8.53
  • Technical
  • Relative Strength Index (RSI)
  • SYBX 45.23
  • TKLF 58.90
  • Support Level
  • SYBX $1.31
  • TKLF $3.52
  • Resistance Level
  • SYBX $1.40
  • TKLF $4.12
  • Average True Range (ATR)
  • SYBX 0.07
  • TKLF 0.20
  • MACD
  • SYBX 0.00
  • TKLF 0.02
  • Stochastic Oscillator
  • SYBX 60.61
  • TKLF 69.44

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: